Protein isolation from cell lysate can represent a significant challenge. The most efficient way to purify a protein is through the use of target-specific affinity ligands. Development of such affinity ligands, in most cases requires the availability of the target protein in a pure form. Thus, isolating the protein from the cell lysate requires affinity ligands, while developing affinity ligands requires a pure protein. Aptamerfacilitated Protein Isolation from Cells (AptaPIC) resolves this loop problem. AptaPIC is a technique that allows the development of aptamers for a protein in a context of a cell lysate, without any prior purification steps, and the subsequent utilization of the developed aptamers for protein isolation from the cell lysate.
Introduction
While over-expression of recombinant proteins in cell cultures is a fairly standard procedure, the purification of such proteins from the cell lysate remains a lengthy and a labor-intensive process. This is especially true of newly discovered proteins for which no standard purification protocols are established. Affinity purification remains the most efficient and high-yielding mode of protein purification, but it is limited by a scarce availability of target-specific affinity ligands 1 .
This is complicated by the fact that the development of target-specific affinity ligands, antibodies being the most commonly used type, often requires the availability of the target protein in a pure form. While the use of genetically fused affinity tags is common in purification of proteins, their use may often introduce unwanted effects, such as changes in target protein conformation, decreased protein expression levels, and toxicity to host cells 2 . Moreover, it is often difficult to efficiently cleave off an affinity tag without affecting the target protein.
The need for introduction of affinity tags can be overcome by using targetspecific affinity ligands, such as aptamers. Aptamers are short 20-100 nucleotide RNA or DNA molecules that can bind their target molecules with high affinity and specificity.
AptaPIC is a technique that allows for: (1) the development of aptamers for a single protein target in the context of a crude cell lysate; (2) and the subsequent use of the developed aptamers in affinity purification of the target protein 3 . This technique was developed to shorten the optimization time for purification of novel protein targets, while achieving high-quality of purification. Figure 1 summarizes the major steps involved in AptaPIC. To make the generation of target-specific aptamers possible in the context of a cell lysate, AptaPIC employs the strategy of alternating positive and negative selection steps. In positive selection, the DNA library is exposed to the target-containing cell lysate (i.e. the lysate of cells in which the target protein is over-expressed) and the bound fraction of DNA is collected and retained for further processing. This step results in the enrichment of the DNA pool with aptamers for both the target protein and for the non-target components of the cell lysate. To eliminate these non-target-specific aptamers, the step of negative selection is introduced. In this step, the enriched DNA pool obtained in the positive aptamer selection step is exposed to the target-free cell lysate (i.e. the lysate of the cells which were transformed with an empty vector), but in contrast to the positive selection step, the non-bound fraction of DNA is collected. The success of aptamer generation through AptaPIC strongly depends on whether the target-containing (positive) and the target-free (negative) cell lysates meet two conditions. The first condition is that the positive cell lysate contains the target protein in the soluble form at a sufficiently high proportion. We have shown that AptaPIC is effective with over-expression levels of the target protein as low as 5% of total protein in the cell lysate. It is advised, however, that the target protein is to be expressed at levels of 10-30% of total protein in the cell lysate. Thus, for best results it important to select a high-yielding protein expression system, such as E. coli BL21 (DE3). The second condition is that the negative cell lysate resembles the positive cell lysate as closely as possible, with the exception of lacking the target protein.
As the strategy of alternating positive and negative selection steps will yield aptamers to any components that are differentially expressed between the two cell lysates, it is important to eliminate any differences in expression levels of such components that can arise due to differences in handling. Thus, the best strategy for obtaining the negative cell lysate is to transform the batch of host cells with an empty vector, and to expose them to the same manipulations as the target-expressing cells. This will ensure that components such as antibiotic resistance agents and transcription/translation machinery agents are present in the negative cell lysates at comparable levels to the positive cell lysate. As requirements for protein expression differ from target to target, the procedure for protein expression is not discussed in this protocol. While this protocol focuses on bacterial protein expression, it can be modified to work with other expression systems, as long as the two previously discussed conditions are met.
In this protocol we utilize capillary electrophoresis (CE) for the separation of bound and non-bound DNA sequences. While other partitioning methods are compatible with AptaPIC, due to its high resolving power, the use of CE significantly decreases the time of aptamer generation while maintaining high stringency 4, 5 . In particular, we use Non-Equilibrium Capillary Electrophoresis of Equilibrium Mixtures (NECEEM) mode of CE. In addition to partitioning, NECEEM can also be used to make quantitative measurements of equilibrium and rate constants, allowing for convenient affinity characterization of the obtained aptamer pools 6 . You should be familiar with the basics of NECEEM and capillary electrophoresis before attempting this protocol 5 .
To reduce nuclease-facilitated degradation of the DNA ligands and the negative effects of DNA-binding proteins on the efficiency of aptamer generation, AptaPIC uses masking DNA, the sequence of which is chosen such that it cannot be PCR amplified along with the molecules of the DNA library. The choice of the concentration of the masking DNA has a significant effect on the efficiency of AptaPIC. If the chosen concentration of masking DNA is too low, it will cause the saturation of the aptamer pool with nonaptamer sequences that are collected as a result of their non-specific binding to the components of the cell lysate. If the chosen concentration of masking DNA is too high, it will cause the loss of aptamer sequences in the negative selection steps. Masking DNA concentration titration step, described in this protocol, is performed to determine the minimum concentration of the masking DNA that achieves the desired levels of suppression of DNA degradation and non-specific binding. The determined minimum masking DNA concentration should be used in the DNA selection steps.
Amplification of heterogeneous pools of DNA through PCR often results in accumulation of disruptive byproducts 7 . Accumulation of these byproducts is dependent on the number of amplification cycles. It is thus important to identify an optimal number of amplification cycles for each pool obtained during AptaPIC. This protocol describes a quantitative PCR-based approach for determination of this optimum. As aptamers are single-stranded DNA ligands, this protocol also includes a step of asymmetric PCR that results in enrichment of the DNA pools with aptamer strands over their complimentary strands.
During aptamer pool generation steps, some uncertainty will always be present regarding the specificity of the emerging aptamer pools. If the positive and the negative cell lysates are not balanced properly, AptaPIC may produce aptamer pools with high cross-reactivity to non-target components of the cell lysate. As a final evaluation of specificity of the acquired aptamer pool, its ability to isolate the target protein from the cell lysate should be tested. This protocol describes an aptamer-facilitated protein pulldown test that will allow such characterizations to be made. This step should not be viewed as a preparative method. Once an aptamer pool with desired characteristic is obtained, it can be used in highscale column chromatography procedures 8 . 
Materials

Reagents
Reagent setup:
• Cell lysates Use a high-yielding bacterial protein expression system, such as BL21 (DE3) to express the target protein. Lysis buffer should be similar to the SB, but with added protease inhibitor cocktail, according to manufacturer's instructions. Lyse the bacterial cells either by sonication or using a French cell press. CRITICAL: A high level of the target protein over-expression is key for successful aptamer selection. Target expression levels at 10% to 30% of total protein in soluble fraction of the cell lysate are optimal.
• Negative cell lysate Transform the host bacterial cells with an empty vector, and expose them to the same manipulations as the cells that were transformed with the target-encoding vector. This includes the treatment with the expression-inducing agent, such as IPTG.
CRITICAL:
The cell lysate for negative selection should resemble the target-containing cell lysate as closely as possible, with the exception of not containing the target protein.
• Oligonucleotide library Resuspend the naive library in DSB to a concentration of 100 mM. The library can be stored at -20 °C for several years. CRITICAL: Choose manual mixing when ordering the library to ensure a 1:1:1:1 ratio of the four nucleotides in the randomized region of the library.
• Oligonucleotide PCR primers PCR primers should be HPLC-purified or PAGE-purified by the supplier. Resuspend the primers in DNA storage buffer to a concentration of 10 mM.
• Buffers and solutions All solutions and buffers should be filtered through a 0.22-µm filter before use.
• Selection buffer Choose a buffer that would ensure the native state of the target. The buffer should preferably have less than 200 mM total salts, and its viscosity should be similar to that of water.
• SDS-PAGE Select a protocol appropriate for the available equipment. We suggest using gradient polyacrylamide gels, as they work especially well with complex samples, as cell lysates. Gradient of 10% to 17% polyacrylamide works best with most protein targets. Use an SDS-containing loading buffer. 
2
Divide the supernatants from step 1 (the soluble fractions of the cell lysates) into 10 µL aliquots and store at -80 °C.
3
Perform SDS-PAGE with the positive cell lysate to ensure that the target protein is in the soluble fraction.
4
Using the BCA protein assay kit, measure the total protein concentration in both the positive and the negative cell lysates, following the manufacturer's instructions.
PAUSE POINT The cell lysates should be stored at -80 °C for up to two months.
Capillary preconditioning and library preparation TIMING: 0.5 h
5
Rinse every new capillary with approximately four capillary volumes of each of the capillary rinsing solutions: 100 mM HCl, 100 mM NaOH, ddH 2 O and RB. Maintain the order of rinsing solutions as listed. Repeat these steps immediately before and after every CE run.
6
Prepare 10 µL of 500 µM naive DNA library in SB. Heat the mixture in a thermal cycler to 94 °C and cool down to 20 °C at a rate of 0.5 °C per s. In future steps, when preparing equilibrium mixtures, treat all the DNA library samples and DNA aptamer samples in this manner. CRITICAL STEP: The temperature treatment increases the variety of secondary and tertiary structures of the single-stranded DNA oligonucleotides.
7
Prepare a 100 µM solution of the temperature-treated DNA library (from step 6) in 100 µL SB.
Determination of library and fluorescein migration times
Prepare a 10 µL sample of equilibrium mixture with the following components: 10 µM of DNA library and 100 µM of each of the masking DNAs. Incubate for 10 minutes at room temperature.
Inject 150 nL of the mixture from step 8 into the capillary and perform NECEEM in RB at 375 V cm -1 (normal polarity and positive electrode at the injection end). Usually, 60 min is sufficient to observe the free DNA component. See troubleshooting.
10
Determine the migration time of the DNA library to the end of the capillary. This is the migration time of the free DNA component of the equilibrium mixture. CRITICAL STEP: For CE instruments with on-column detection, the migration time of each analyte to the detector does not equal to the elution time of the analyte from the capillary. For fraction collection purposes, approximate the time it takes for each specie to reach the end of the capillary by multiplying the migration time of the analyte to the detector by the ratio between L total to L detection , i.e. 1.14 for the 80 cm capillary.
11
As described in step 9, perform NECEEM with the same equilibrium mixture, but with added 100 nM of fluorescein. Fluorescein will act as the collection window migration marker.
12
Determine the migration time of fluorescein to the end of the capillary and its relative elution time to the free DNA.
Masking DNA concentration titration TIMING: 2 h
13
Prepare 10 µL of equilibrium mixture with the following components: 10 µM of DNA library, 20 µg mL -1 of positive cell lysate, 100 nM of fluorescein. Incubate for 10 minutes at room temperature.
14 Run the sample in CE as described in step 9. Observe the peaks that correspond to species other than the fluorescein and the free DNA. CRITICAL STEP: These peaks appear as a result of DNA degradation and non-specific interaction with the cell lysate (lysate peaks). These peaks need to be suppressed by masking DNA.
15
Prepare three 10 µL equilibrium mixtures with varying concentrations of masking DNAs. The equilibrium mixtures should contain the following components: 10 µM of DNA library, 20 µg mL -1 of positive cell lysate, 100 nM of fluorescein, and each of the masking DNA's at concentrations of 100 µM, 1 mM and 10 mM respectively per each sample. Incubate each mixture for 10 minutes at room temperature before performing NECEEM analysis as described in step 9. Observe the effect of varying masking DNA concentrations on the lysate peaks. Select the lowest masking DNA concentration that has a significant suppressing effect on these peaks. While full suppression is desirable, do not increase the concentration of the masking DNAs above 10 mM.
Positive Selection TIMING: 1 h
16
Before rinsing the capillary as described in step 5, rinse it with 4 capillary volumes of RNase-AWAY solution.
17
Prepare 10 µL equilibrium mixture with the following components: 10 µM of DNA library, 20 µg mL -1 of positive cell lysate, 100 nM of fluorescein, and the determined concentration of masking DNAs from step 15. Incubate for 10 minutes at room temperature.
18
Initiate NECEEM as described in step 9, with the following modifications. At the capillary outlet, place a tube with 5 µL of SB. Collect the eluent from the beginning of CE run, to the elution of the fluorescein peak. At this point, briefly pause the electric current, switch the outlet of the capillary into an outlet containing RB, and continue the electric current. Stop the separation after the free DNA component of the equilibrium mixture elutes. Collection window is illustrated in figure 2 .
19
Incubate the collected fraction for 15 min at room temperature.
Negative Selection TIMING: 1 h
20
21
Prepare 10 µL equilibrium mixture with the following components: 5 µL of the DNA fraction from step 19, 20 µg mL -1 of negative cell lysate, 100 nM of fluorescein, and the determined concentration of masking DNAs from step 15. Incubate for 10 min at room temperature.
22
Perform NECEEM as described in step 9, with the following modifications. At the capillary outlet, place a reservoir containing RB. When the peak corresponding to fluorescein starts eluting, briefly pause the electric current, switch the outlet of the capillary into a tube with 5 µL of SB, and continue the electric current. Keep collecting the eluents 5 minutes after the expected elution time of the free DNA component, from step 9. Collection window is illustrated in figure 2 .
PAUSE POINT The collected fraction should be stored at -20 °C. DNA in the fractions is stable for several months. 
Determination of optimum number of cycles for preparative PCR TIMING: 2 h 23
Set up 20 µL amplification reaction mixture for the fraction collected in step 22, with the components as described in table 1. 
25
Real-time PCR produces an S-shaped amplification curve (product yield versus number of cycles). Determine how many cycles are required for the reaction mixture to generate the product at a level of 50-60% of the maximum. This is the number of cycles required to generate the optimal amount of amplified library product in the subsequent preparative PCR.
Preparative PCR TIMING: 2 h
26
Set up 40 µL amplification reaction mixture for the fraction collected in step 22, with the components as described in table 3. 
CRITICAL STEP:
A pair of FAM-labeled and biotin-labeled primers is used in this PCR reaction to produce a FAM-labeled aptamer and a biotin-labeled complementary strand. Biotin facilitates separation of double-stranded PCR products from single-stranded aptamers, whereas FAM allows LIF detection in CE.
27
In addition to the sample from step 26, set up a 40 µL control mixture, with the components as described in table 3, but with ddH 2 O instead of the template.
28
Amplify the samples from steps 26 and 27 using the PCR program detailed in table 4. There is no need to measure the fluorescence signal from this reaction. Perform the number of cycles that was determined to be optimal for amplification of the pool, in step 25. 
29
Transfer 5 µL of each of the amplification products from step 27 into new sample tubes. Precondition a 50 cm capillary as described in step 5. Using this 50 cm capillary, perform NECEEM on each of the samples, as described in step 9. The electropherogram for the control sample should contain only a single peak, representing the labeled primer, while the sample from step 26 should also have a second smaller peak, representing the double-stranded DNA amplification product. The presence of the double-stranded DNA peak will confirm the efficiency of the PCR amplification step.
Asymmetric PCR TIMING: 2 h 30
Set up 40 µL amplification reaction mixture for the products of amplification reaction from step 28, using the components as described in table 5. 
33
Mix 40 µL of PCR-amplified samples from step 28 with 40 µL BWB.
34
Resuspend the beads from step 32 in the sample solutions from step 33, and gently mix. Incubate at room temperature for 20 min, gently mixing every five min to facilitate faster binding of DNA to the beads.
35
Pull down the beads from the solution using a magnetic separator and collect the supernatant. Load the supernatant on to the molecular cut-off filters. Discard the beads. CRITICAL STEP: Magnetic beads separate the single-stranded aptamers from double-stranded PCR amplification products.
36
Centrifuge the molecular cut-off filters with the supernatant from step 35, at 7,000 × g for 20 minutes at 15° C.
37
Load 200 µL of SB on to the filter and repeat step 36. Wash the filters in this manner three more times. Discard the flow-through as the test tube becomes filled. CRITICAL STEP: Molecular cut-off filters are used to isolate the DNA aptamers from PCR primers.
38
Load 15 µL of SB on to the filter and incubate, without centrifugation, for 30 min at 15° C. CRITICAL STEP: In this step, retained DNA is eluted from the filter.
39
Place the filter up-side-down into a new clean test tube and centrifuge at 7,000 × g for 10 minutes at 15° C.
40
Collect the eluted fraction and discard the filters. The collected fraction contains the DNA aptamer pool.
PAUSE POINT Amplified aptamer pools can be stored at -20 °C for several years.
Approximation of resultant pool concentration TIMING: 2 h
41
Prepare the following dilutions of the FAM-Forward primer: 50nM, 200 nM, 500nM and 1 µM.
42
Perform NECEEM as described in step 9 with each of the dilutions of the FAM-labeled primer. Plot the heights of the produced peaks against primer concentrations to obtain a standard curve. Using the standard curve and the peak height from step 41 roughly approximate the concentration of the aptamer pool.
Affinity analysis of aptamer pools TIMING: 2 h 43
Use temperature treatment, as described in step 6, on 5 µL of aptamer pool from step 40.
44
Prepare a 5 µL equilibrium mixture with the following components: 1 µL of aptamer pool from step 43, 20 µg mL -1 of positive cell lysate, 100 nM of fluorescein, and the concentration of masking DNAs as used in step 15. Incubate for 10 min at room temperature.
45
Use a 50-cm capillary for the following CE run. Rinse the capillary as described in step 5.
46
Inject 50 nL of the equilibrium mixture from step 44 into the capillary and run NECEEM in RB at 375 V cm -1 (normal polarity and positive electrode at the injection end).
47
Compare the resultant electropherogram to the one produced in step 12. Any peak, or peaks, that increase in area should be suspected to correspond to complexes between the target protein and the DNA aptamers. Using equation 1, calculate the bulk EC 50 value of the aptamer pool to the target in using the combined areas of the suspected peaks. See troubleshooting. are the total concentrations of the target and DNA, respectively; A 1 is the area of the peak of free DNA divided by the migration time of free DNA, A 2 is the area of the peak of DNA that dissociated from the complex during NECEEM divided by the migration time of free DNA and A 3 is the area of the peak of the intact complex that reached the detector divided by the migration time of the complex. EC 50 is a measure of an effective abundance of aptamers in the library, which is used for qualitatively monitoring the progress of selection -a decrease of this value throughout the steps of partitioning indicates that the selection is progressing. The division of areas by corresponding migration times is performed to ensure that peak areas are proportional to the amounts of the species. This procedure is necessary for CE instruments with the on-column detection mode only. For CE instruments with past-column detection, normalization by time is not required.
CRITICAL STEP:
Peaks representing the complexes between DNA aptamers and the target protein might not become distinguishable after the first two or three rounds of selection.
PAUSE POINT Use the data collected from these steps for subsequent rounds at your convenience.
Subsequent aptamer selection rounds TIMING: 3 days per round of selection
48
Subsequent rounds of aptamer selection should be repeated in the same manner as described above in steps 16 to 47. Some modifications are as follows: In all steps where the original DNA library is used, it should be substituted with the aptamer pool obtained in the previous round. In all equilibrium mixtures add the DNA aptamer pool to a final concentration of approximately 100-200 nM. To maintain the ratio between aptamer DNA and masking DNA, reduce the concentration of the masking DNAs by 50 times.
49
When the peaks suspected to represent the complex between aptamers and the target protein become distinguishable, narrow down the collection window around these peaks.
50
Repeat aptamer selection rounds until the pool displays the desired EC 50 value, or until no improvements to are observed for three consecutive rounds. See troubleshooting.
Aptamer pool biotinylation TIMING: 4 h
51
Set up a 120 µL amplification reaction mixture for the fraction collected in the step 40 of the corresponding selection round, with the components as described in table 6. Load the product of the PCR amplification on to the molecular cut-off filters.
56
Centrifuge the molecular cut-off filters with the supernatant from step 55, at 7,000 × g for 20 minutes at 15° C.
57
Load 200 µL of SB on to the filter and repeat step 56. Wash the filters in this manner three more times. Discard the flow-through as the test tube becomes filled. CRITICAL STEP: Molecular cut-off filters are used to isolate the DNA aptamers from PCR primers.
58
59
60
Collect the eluted fraction and discard the filters. The collected fraction contains the biotinylated DNA aptamer pool.
PAUSE POINT Biotinylated aptamer pools can be stored at -20 °C for several months.
Aptamer-facilitated target protein pull-down TIMING: 4 h
61
Use temperature treatment, as described in step 6, on 15 µL of biotinylated aptamer pool from step 60.
62
Treat a sample of 500 µM naive DNA library as described in step 6. From the temperature-treated stock prepare 100 µL of 100 µM naive DNA library in SB. CRITICAL STEP: The naive DNA library will act as a negative control.
63
Prepare 50 µL equilibrium mixtures with the each of the samples from steps 60 and 61: 15 µL of DNA sample, 20 µg mL -1 of positive cell lysate, and the concentration of masking DNAs as in step 48. Incubate for 10 minutes at room temperature.
64
For each pull-down sample from step 63, aliquot 50 µL streptavidin beads into an empty test tube. Wash the beads twice with 200 µL bead washing buffer. After each wash, precipitate the beads from the solution with a magnetic bead separator.
65
After the final washing step, remove the bead washing buffer and add the pull-down samples to the beads. Incubate at room temperature for 20 min, gently mixing every five minutes to facilitate faster binding of DNA to the beads.
66
Pull down the beads from the solution using a magnetic separator and separate the beads and the supernatant. Preserve the supernatant for further analysis through SDS-PAGE. Wash the beads three times with 100 µL of bead washing buffer. After each wash, precipitate the beads from the solution with a magnetic bead separator.
67
After the final washing step, remove the BWB and add SDS-containing loading buffer according to the employed SDS-PAGE protocol. Maintain a low volume, preferably less than 20 µL. Incubate at 99 °C for 5 min.
68
Pull down the beads from the solution using a magnetic separator and collect the supernatant. Load directly on to a polyacrylamide gel for SDS-PAGE analysis.
